Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2025-04-20
2025-09-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fatigue and Sleep Quality in Multiple Sclerosis Patients
NCT05456464
Acupuncture or MBSR for Patients With Fatigue and MS
NCT01864707
The Effects of Relaxation Techniques on Pain, Fatigue and Kinesiophobia in Multiple Sclerosis Patients: A Three Arms Randomized Trial
NCT04833673
Acupressure in MS Patients
NCT06755463
the Effect of Reflexology in Migraine Patients
NCT06828315
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Reiki group
Group where Reiki was applied
Reiki
Reiki
Self-acupressure applied group
Group where Self-acupressure was applied
Self-Acupressure
Self-Acupressure
Control
Group with no intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reiki
Reiki
Self-Acupressure
Self-Acupressure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients who have no communication problems
3. Patients who are 18 years of age or older
4. Patients who live in the center
5. Patients who have no scratches or deformities in the treatment area
6. Patients who do not smoke, use drugs, or use tranquilizers, and are not pregnant
7. Patients who have been receiving MS treatment for more than three months
Exclusion Criteria
2. Have dyspnea
3. Have anemia
4. Have diabetes
5. Have received corticosteroid treatment in the last three months
6. Have had an MS attack in the last three months
7. Have an autoimmune disease other than multiple sclerosis
8. Have signs of infection
9. Have a thyroid problem
10. Are taking psychostimulant medications
11. Have anxiety or depression detected in outpatient clinic screenings
12. Refuse to participate in the study
13. Have another known neurological system disease (dementia, Alzheimer's, etc.)
14. Have a communication barrier will not be included in the study.
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Firat University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Furkan BİLEK
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Caner F Demir, MD
Role: STUDY_CHAIR
Firat University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Muğla Sıtkı Koçman University
Muğla, Fethi̇ye, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022/ 11- 14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.